Liquid biopsies come of age: towards implementation of circulating tumour DNA

被引:1893
作者
Wan, Jonathan C. M. [1 ,2 ]
Massie, Charles [1 ,2 ]
Garcia-Corbacho, Javier [1 ,3 ]
Mouliere, Florent [1 ,2 ]
Brenton, James D. [1 ,2 ]
Caldas, Carlos [1 ,2 ,4 ]
Pacey, Simon [2 ,4 ]
Baird, Richard [2 ,4 ]
Rosenfeld, Nitzan [1 ,2 ]
机构
[1] Cancer Res UK Cambridge Inst, Li Ka Shing Ctr, Robinson Way, Cambridge CB2 0RE, England
[2] Canc Res UK Cambridge Ctr, Cambridge CB2 0RE, England
[3] Hosp Clin Barcelona, IDIBAPs, Clin Inst Haematol & Oncol Dis, Clin Trials Unit, Carrer Villarroel 170, E-08036 Barcelona, Spain
[4] Univ Cambridge, Dept Oncol, Hutchison MRC Res Ctr, Box 197,Cambridge Biomed Campus, Cambridge CB2 0XZ, England
基金
欧洲研究理事会;
关键词
CELL-FREE DNA; COLORECTAL-CANCER PATIENTS; PRIMARY BREAST-CANCER; FACTOR RECEPTOR MUTATIONS; COPY NUMBER ABERRATIONS; FREE NUCLEIC-ACIDS; BARR-VIRUS DNA; LUNG-CANCER; PLASMA DNA; ACQUIRED-RESISTANCE;
D O I
10.1038/nrc.2017.7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Improvements in genomic and molecular methods are expanding the range of potential applications for circulating tumour DNA (ctDNA), both in a research setting and as a `liquid biopsy' for cancer management. Proof-of-principle studies have demonstrated the translational potential of ctDNA for prognostication, molecular profiling and monitoring. The field is now in an exciting transitional period in which ctDNA analysis is beginning to be applied clinically, although there is still much to learn about the biology of cell-free DNA. This is an opportune time to appraise potential approaches to ctDNA analysis, and to consider their applications in personalized oncology and in cancer research.
引用
收藏
页码:223 / 238
页数:16
相关论文
共 237 条
[61]   Cancer therapy monitoring in xenografts by quantitative analysis of circulating tumor DNA [J].
Gorges, Tobias M. ;
Schiller, Johanna ;
Schmitz, Arndt ;
Schuetzmann, Daniel ;
Schatz, Christoph ;
Zollner, Thomas M. ;
Krahn, Thomas ;
von Ahsen, Oliver .
BIOMARKERS, 2012, 17 (06) :498-506
[62]   Circulating free DNA in plasma or serum as biomarker of carcinogenesis: Practical aspects and biological significance [J].
Gormally, Emmanuelle ;
Caboux, Elodie ;
Vineis, Paolo ;
Hainaut, Pierre .
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 2007, 635 (2-3) :105-117
[63]   TP53 and KRAS2 mutations in plasma DNA of healthy subjects and subsequent cancer occurrence:: A prospective study [J].
Gormally, Emmanuelle ;
Vineis, Paolo ;
Matullo, Giuseppe ;
Veglia, Fabrizio ;
Caboux, Elodie ;
Le Roux, Emilie ;
Peluso, Marco ;
Garte, Seymour ;
Guarrera, Simonetta ;
Munnia, Armelle ;
Airoldi, Luisa ;
Autrup, Herman ;
Malaveille, Christian ;
Dunning, Alison ;
Overvad, Kim ;
Tjonneland, Anne ;
Lund, Eiliv ;
Clavel-Chapelon, Francoise ;
Boeing, Heiner ;
Trichopoulou, Antonia ;
Palli, Domenico ;
Krogh, Vittorio ;
Tumino, Rosario ;
Panico, Salvatore ;
Bueno-de-Mesquita, H. Bas ;
Peeters, Petra H. ;
Pera, Guillem ;
Martinez, Carmen ;
Dorronsoro, Miren ;
Barricarte, Aurelio ;
Navarro, Carmen ;
Quiros, Jose Ramon ;
Hallmans, Goran ;
Day, Nicholas E. ;
Key, Timothy J. ;
Saracci, Rodolfo ;
Kaaks, Rudolf ;
Riboli, Elio ;
Hainaut, Pierre .
CANCER RESEARCH, 2006, 66 (13) :6871-6876
[64]   Circulating tumor DNA to monitor treatment response and detect acquired resistance in patients with metastatic melanoma [J].
Gray, Elin S. ;
Rizos, Helen ;
Reid, Anna L. ;
Boyd, Suzanah C. ;
Pereira, Michelle R. ;
Lo, Johnny ;
Tembe, Varsha ;
Freeman, James ;
Lee, Jenny H. J. ;
Scolyer, Richard A. ;
Siew, Kelvin ;
Lomma, Chris ;
Cooper, Adam ;
Khattak, Muhammad A. ;
Meniawy, Tarek M. ;
Long, Georgina V. ;
Carlino, Matteo S. ;
Millward, Michael ;
Ziman, Melanie .
ONCOTARGET, 2015, 6 (39) :42008-42018
[65]   Distinct subclonal tumour responses to therapy revealed by circulating cell-free DNA [J].
Gremel, G. ;
Lee, R. J. ;
Girotti, M. R. ;
Mandal, A. K. ;
Valpione, S. ;
Garner, G. ;
Ayub, M. ;
Wood, S. ;
Rothwell, D. G. ;
Fusi, A. ;
Wallace, A. ;
Brady, G. ;
Dive, C. ;
Dhomen, N. ;
Lorigan, P. ;
Marais, R. .
ANNALS OF ONCOLOGY, 2016, 27 (10) :1959-1965
[66]   Molecular Triage of Premalignant Lesions in Liquid-Based Cervical Cytology and Circulating Cell-Free DNA from Urine, Using a Panel of Methylated Human Papilloma Virus and Host Genes [J].
Guerrero-Preston, Rafael ;
Valle, Blanca L. ;
Jedlicka, Anne ;
Turaga, Nitesh ;
Folawiyo, Oluwasina ;
Pirini, Francesca ;
Lawson, Fahcina ;
Vergura, Angelo ;
Noordhuis, Maartje ;
Dziedzic, Amanda ;
Perez, Gabriela ;
Renehan, Marisa ;
Guerrero-Diaz, Carolina ;
Rodriguez, Edgar De Jesus ;
Diaz-Montes, Teresa ;
Orengo, Jose Rodriguez ;
Mendez, Keimari ;
Romaguera, Josefina ;
Trock, Bruce J. ;
Florea, Liliana ;
Sidransky, David .
CANCER PREVENTION RESEARCH, 2016, 9 (12) :915-924
[67]   Differential strand separation at critical temperature: A minimally disruptive enrichment method for low-abundance unknown DNA mutations [J].
Guha, Minakshi ;
Castellanos-Rizaldos, Elena ;
Liu, Pingfang ;
Mamon, Harvey ;
Makrigiorgos, G. Mike .
NUCLEIC ACIDS RESEARCH, 2013, 41 (03) :e50
[68]  
Han B., 2015, Ann Oncol, V26
[69]   Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing [J].
Heitzer, Ellen ;
Ulz, Peter ;
Belic, Jelena ;
Gutschi, Stefan ;
Quehenberger, Franz ;
Fischereder, Katja ;
Benezeder, Theresa ;
Auer, Martina ;
Pischler, Carina ;
Mannweiler, Sebastian ;
Pichler, Martin ;
Eisner, Florian ;
Haeusler, Martin ;
Riethdorf, Sabine ;
Pantel, Klaus ;
Samonigg, Hellmut ;
Hoefler, Gerald ;
Augustin, Herbert ;
Geigl, Jochen B. ;
Speicher, Michael R. .
GENOME MEDICINE, 2013, 5
[70]   Establishment of tumor-specific copy number alterations from plasma DNA of patients with cancer [J].
Heitzer, Ellen ;
Auer, Martina ;
Hoffmann, Eva Maria ;
Pichler, Martin ;
Gasch, Christin ;
Ulz, Peter ;
Lax, Sigurd ;
Waldispuehl-Geigl, Julie ;
Mauermann, Oliver ;
Mohan, Sumitra ;
Pristauz, Gunda ;
Lackner, Carolin ;
Hoefler, Gerald ;
Eisner, Florian ;
Petru, Edgar ;
Sill, Heinz ;
Samonigg, Hellmut ;
Pantel, Klaus ;
Riethdorf, Sabine ;
Bauernhofer, Thomas ;
Geigl, Jochen B. ;
Speicher, Michael R. .
INTERNATIONAL JOURNAL OF CANCER, 2013, 133 (02) :346-356